Abstract:ETHNOPHARMACOLOGICAL RELEVANCE: Diabetic nephropathy (DN) is a major complication of diabetes. The kidney disease develops in nearly 20%-40% of type 2 diabetes (T2D) patients. Ginseng is the root of Panax ginseng C. A. Meyer and has been used in prevention and treatment of diseases for more than 2000 years as a traditional oriental medicine. The 20(R)-ginsenoside Rg3, an active saponin isolated from ginseng, can prevent and treat many diseases. The object of this research was to explore the alleviative effects of 20(R)-Rg3 on DN in mice.MATERIALS AND METHODS: The T2D animal model was induced by continuous access to a high fat diet (HFD) combined with a single injection of 100 mg/kg streptozotocin (STZ) in C57BL/6 mice. The mice were treated by oral gavage of the 20(R)-Rg3 (10, 20 mg/kg) for 8 weeks. Functional and histopathological analyses of the kidneys were then performed. Protein expression levels of MAPKs and NF-κB signal pathways in the kidney were evaluated by western blotting. The expressions of HO-1 and NF-κB in the kidney were measured by fluorescent labeling staining. Other assessments including fasting blood glucose (FBG) levels, blood lipids, oxidative indicators, and inflammatory factors were all performed.RESULTS: Abnormally elevated FBG levels were observed in HFD/STZ mice, contributing significantly to the occurrence of DN. Simultaneously, HFD/STZ mice showed the rise of serum total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels, and the decrease in high density lipoprotein cholesterol (HDL-C). DN was evidenced by the overproduction of malondialdehyde (MDA), decreased levels of superoxide dismutase (SOD) and catalase (CAT) enzymatic activities, high levels of serum blood urea nitrogen (BUN) and creatinine (Cr). Simultaneously, the results of the immunofluorescence assay showed an increased expression level in NF-κB p65 while a decrease in antioxidant enzyme HO-1 was observed. Herein, 20(R)-Rg3 treatment for 8 weeks not only attenuated FBG levels and advanced glycation end products (AGEs) levels but also improved insulin (INS) level, blood lipids, oxidative stress, and renal function by regulating MAPKs and NF-κB signal pathways in DN mice.CONCLUSION: Taken together, the findings from the present study explicitly confirmed that 20(R)-Rg3 exerted ameliorative effects on DN mice via improving anti-oxidative activity and reducing renal inflammation.

What problem does this paper attempt to address?

The problem this paper attempts to address is the investigation of the alleviating effects and mechanisms of 20(R)-Rg3 (an active saponin isolated from ginseng) on diabetic nephropathy (DN) in type 2 diabetic mice induced by high-fat diet/streptozotocin (HFD/STZ). Specifically, the study aims to verify whether 20(R)-Rg3 can improve the symptoms of diabetic nephropathy by regulating the MAPK/NF-κB signaling pathway, including lowering blood glucose and lipid levels, reducing oxidative stress and inflammatory responses, and decreasing apoptosis. ### Main Research Content: 1. **Model Establishment**: Inducing type 2 diabetes in C57BL/6 mice by feeding them a high-fat diet and injecting streptozotocin (STZ) to create a diabetic nephropathy model. 2. **Drug Treatment**: Oral administration of different doses of 20(R)-Rg3 (10 mg/kg and 20 mg/kg) to diabetic mice for 8 weeks. 3. **Functional and Pathological Analysis**: Evaluating changes in renal function indicators (such as blood urea nitrogen BUN and creatinine Cr), blood biochemical indicators (such as fasting blood glucose FBG, blood lipids TC and TG), oxidative stress indicators (such as MDA and SOD), and inflammatory factors (such as TNF-α and IL-1β). 4. **Signaling Pathway Detection**: Detecting changes in the expression of proteins related to the MAPK and NF-κB signaling pathways using Western blot and immunofluorescence staining techniques. ### Main Findings: - **Blood Glucose and Lipids**: 20(R)-Rg3 significantly reduced fasting blood glucose levels in diabetic mice and improved the lipid profile, including lowering total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C), and increasing high-density lipoprotein cholesterol (HDL-C). - **Oxidative Stress**: 20(R)-Rg3 reduced the production of the oxidative stress marker MDA and increased the activity of the antioxidant enzyme SOD. - **Inflammatory Response**: 20(R)-Rg3 inhibited the expression of inflammatory factors TNF-α and IL-1β, reducing the inflammatory response in renal tissues. - **Signaling Pathway**: 20(R)-Rg3 inhibited the activation of the MAPK and NF-κB signaling pathways, thereby reducing inflammation and apoptosis. - **Histopathology**: 20(R)-Rg3 improved the histopathological damage in the kidneys of diabetic nephropathy mice, reducing glomerular cell nuclear overflow and tubular cell nuclear disarray. ### Conclusion: In summary, 20(R)-Rg3 has a significant alleviating effect on diabetic nephropathy by improving antioxidant activity and reducing renal inflammation. This finding provides new scientific evidence for the prevention and treatment of diabetic nephropathy with 20(R)-Rg3.

Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-κB signaling pathways in C57BL/6 mice